Inventor · disambiguated record
Harshani R. Lawrence
Also filed as: LAWRENCE HARSHANI · LAWRENCE HARSHANI R · LAWRENCE HARSHANI RITHMA · LAWRENCE HARSHANI RITHMA RUCHIRANANI
30 granted patents·13 pending applications·43 citations·filing 2005–2025
94Inventor score
Top patents by PatentIndex Score
43 records- 0190US10336734B2Inhibitors of ACK1/TNK2 tyrosine kinaseH LEE MOFFITT CANCER CT & RES·Filed 2016·Granted Jul 2, 2019·7 cites·9 claims
- 0289US8466157B2Proteasome inhibitors having chymotrypsin-like activityLAWRENCE HARSHANI·Filed 2011·Granted Jun 18, 2013·9 cites·18 claims
- 0388US7960434B2Small molecule inhibitors of STAT3 with anti-tumor activityUNIV SOUTH FLORIDA·Filed 2007·Granted Jun 14, 2011·10 cites·16 claims
- 0487US9597329B2Aurora kinase inhibitors and methods of making and using thereofSEBTI SAID M·Filed 2016·Granted Mar 21, 2017·4 cites·12 claims
- 0586US11730726B2Dimeric immuno-modulatory compounds against cereblon-based mechanismsH LEE MOFFITT CANCER CT & RES·Filed 2019·Granted Aug 22, 2023·2 cites·14 claims
- 0685US10526291B2Potent dual BRD4-kinase inhibitors as cancer therapeuticsH LEE MOFFITT CANCER CT & RES·Filed 2018·Granted Jan 7, 2020·2 cites·33 claims
- 0780US12233054B2Dimeric immuno-modulatory compounds against cereblon-based mechanismsH LEE MOFFITT CANCER CT & RES·Filed 2023·Granted Feb 25, 2025·0 cites·13 claims
- 0880US2024368089A1Aurora kinase and janus kinase inhibitors for prevention of graft versus host diseaseH LEE MOFFITT CANCER CT & RES·Filed 2024·Application pending·0 cites
- 0978US12060332B2Aurora kinase and janus kinase inhibitors for prevention of graft versus host diseaseH LEE MOFFITT CANCER CT & RES·Filed 2023·Granted Aug 13, 2024·0 cites·3 claims
- 1076US10954258B2STAT3 dimerization inhibitorsH LEE MOFFITT CANCER CT & RES·Filed 2019·Granted Mar 23, 2021·0 cites·16 claims
- 1176US10106507B2Potent dual BRD4-kinase inhibitors as cancer therapeuticsH LEE MOFFITT CANCER CT & RES·Filed 2015·Granted Oct 23, 2018·2 cites·25 claims
- 1275US10017478B2Inhibitors of ACK1/TNK2 tyrosine kinaseH LEE MOFFITT CANCER CT & RES·Filed 2017·Granted Jul 10, 2018·1 cites·8 claims
- 1374US10806712B2Small molecule inhibitors of STAT3 with anti-tumor activityH LEE MOFFITT CANCER CT & RES·Filed 2019·Granted Oct 20, 2020·0 cites·6 claims
- 1474US2021121427A1Small molecule inhibitors of stat3 with anti-tumor activityH LEE MOFFITT CANCER CT & RES·Filed 2020·Application pending·0 cites
- 1573US9850216B2Inhibitors of ACK1/TNK2 tyrosine kinaseH LEE MOFFITT CANCER CT & RES·Filed 2014·Granted Dec 26, 2017·1 cites·6 claims
- 1673US8623906B2Carboxy isatin hydrazones and their esters as Shp2 inhibitorsWU JIE·Filed 2011·Granted Jan 7, 2014·1 cites·5 claims
- 1771US9878999B2Proteasome chymotrypsin-like inhibition using PI-1833 analogsH LEE MOFFITT CANCER CT & RES·Filed 2013·Granted Jan 30, 2018·1 cites·20 claims
- 1871US2022281828A1Aurora kinase and janus kinase inhibitors for prevention of graft versus host diseaseH LEE MOFFITT CANCER CT & RES·Filed 2021·Application pending·0 cites
- 1970US8673910B2Proteasome inhibitors for selectively inducing apoptosis in cancer cellsLAWRENCE HARSHANI·Filed 2009·Granted Mar 18, 2014·2 cites·21 claims
- 2068US10226439B2Small molecule inhibitors of STAT3 with anti-tumor activityH LEE MOFFITT CANCER CT & RES·Filed 2017·Granted Mar 12, 2019·0 cites·4 claims
- 2168US9249124B2Aurora kinase inhibitors and methods of making and using thereofSEBTI SAID M·Filed 2012·Granted Feb 2, 2016·1 cites·6 claims
- 2267US2025288573A1Dimeric immuno-modulatory compounds against cereblon-based mechanismsH LEE MOFFITT CANCER CT & RES·Filed 2025·Application pending·0 cites
- 2366US9604923B2Small molecule inhibitors of STAT3 with anti-tumor activityH LEE MOFFITT CANCER CT & RES·Filed 2014·Granted Mar 28, 2017·0 cites·2 claims
- 2463US11203576B2Aurora kinase and Janus kinase inhibitors for prevention of graft versus host diseaseH LEE MOFFITT CANCER CT & RES·Filed 2017·Granted Dec 21, 2021·0 cites·11 claims
- 2562US11643396B2BRD4-kinase inhibitors as cancer therapeuticsH LEE MOFFITT CANCER CT & RES·Filed 2020·Granted May 9, 2023·0 cites·10 claims
- 2662US2023303499A1Inhibitors of ack1/tnk2 tyrosine kinaseH LEE MOFFITT CANCER CT & RES·Filed 2021·Application pending·0 cites
- 2762US2024010634A1Pyrimidinyl sulfonamides as inhibitors of ack1/tnk2 tyrosine kinaseH LEE MOFFITT CANCER CT & RES·Filed 2021·Application pending·0 cites
- 2861US12391676B2BRD4-JAK2 inhibitorsH LEE MOFFITT CANCER CT & RES·Filed 2019·Granted Aug 19, 2025·0 cites·10 claims
- 2961US9822135B2STAT3 dimerization inhibitorsH LEE MOFFITT CANCER CT & RES·Filed 2013·Granted Nov 21, 2017·0 cites·17 claims
- 3060US12187686B2BRD4-JAK2 inhibitorsH LEE MOFFITT CANCER CT & RES·Filed 2019·Granted Jan 7, 2025·0 cites·8 claims
- 3160US10494389B2STAT3 dimerization inhibitorsH LEE MOFFITT CANCER CT & RES·Filed 2017·Granted Dec 3, 2019·0 cites·15 claims
- 3258US8987474B2Inhibition of Shp2/PTPN11 protein tyrosine phosphatase by NSC-87877, NSC-117199 and their analogsWU JIE·Filed 2007·Granted Mar 24, 2015·0 cites·11 claims
- 3358US2025339429A1Methods of treating ulk3-associated cancersH LEE MOFFITT CANCER CT & RES·Filed 2023·Application pending·0 cites
- 3457US10738016B2BRD4-kinase inhibitors as cancer therapeuticsH LEE MOFFITT CANCER CT & RES·Filed 2016·Granted Aug 11, 2020·0 cites·15 claims
- 3557US2023348518A1Helicase inhibitors for treatment of medical disordersH LEE MOFFITT CANCER CT & RES·Filed 2021·Application pending·0 cites
- 3657US2024228502A12-phenylamino pyrrolopyrimidines as ack1 inhibitorsH LEE MOFFITT CANCER CT & RES·Filed 2022·Application pending·0 cites
- 3756US10662180B2Proteasome chymotrypsin-like inhibition using PI-1833 analogsH LEE MOFFITT CANCER CT & RES·Filed 2018·Granted May 26, 2020·0 cites·12 claims
- 3856US2024140952A1Inhibitors and degraders of janus kinase 2H LEE MOFFITT CANCER CT & RES·Filed 2022·Application pending·0 cites
- 3956US2011201576A1Small molecule inhibitors of stat3 with anti-tumor activityH LEE MOFFITT CANCER CT & RES·Filed 2011·Application pending·0 cites
- 4054US2023295129A1Inhibitors of ack1/tnk2 tyrosine kinaseH LEE MOFFITT CANCER CT & RES·Filed 2021·Application pending·0 cites
- 4147US11395820B2Small molecules against cereblon to enhance effector t cell functionH LEE MOFFITT CANCER CT & RES·Filed 2017·Granted Jul 26, 2022·0 cites·11 claims
- 4244US2009186900A1CompoundVICKER NIGEL·Filed 2008·Application pending·0 cites
- 4341US8003783B217B-hydroxysteroid dehydrogenase inhibitorsSTERIX LTD·Filed 2005·Granted Aug 23, 2011·0 cites·19 claims
Join the waitlist — get patent alerts
Get an alert when Harshani R. Lawrence files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →